| P2093 | author name string | Lakshmi N Yatham | |
| P2860 | cites work | An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). | Q30482552 |
| | Treatment of bipolar disorder: a systematic review of available data and clinical perspectives | Q33364302 |
| | A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 |
| | Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. | Q33966353 |
| | Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). | Q34000973 |
| | The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. | Q34004814 |
| | Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. | Q34588960 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | Q34616633 |
| | Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials | Q34749757 |
| | Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis | Q34994544 |
| | Mood state at study entry as predictor of the polarity of relapse in bipolar disorder | Q35985601 |
| | The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate | Q35997742 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies | Q36161335 |
| | Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia | Q36711811 |
| | Functioning and disability in bipolar disorder: an extensive review | Q37551519 |
| | Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial | Q38376022 |
| | Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial | Q42609214 |
| | A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression | Q42645277 |
| | Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study | Q43080173 |
| | Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study | Q43145175 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study | Q44627462 |
| | Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone | Q44824135 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Adjunctive aripiprazole in bipolar I depression | Q46055786 |
| | Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). | Q46086886 |
| | The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 |
| | Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). | Q46519540 |
| | A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 |
| | Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study | Q46669710 |
| | Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies | Q46801835 |
| | Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study | Q46886132 |
| | A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. | Q47208132 |
| | Adjunctive aripiprazole in treatment-resistant bipolar depression. | Q51789886 |
| | Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. | Q51900824 |
| | Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. | Q51910102 |
| P921 | main subject | bipolar disorder | Q131755 |
| | bipolar depression | Q56014658 |
| P304 | page(s) | S21-8 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder | |
| P478 | volume | 128 Suppl 1 | |